With no cure, Parkinson’s disease represents a long-term degenerative disorder stemming from the central nervous system. With symptoms that typically come on slowly, they progress…
Most anti-epileptic drugs do not adequately treat severe seizures and behavior deficits and come with a host of side effects. More effective, longer-lasting treatments are…
The Pennsylvania Department of Health’s Commonwealth Universal Research Enhancement (CURE) program awarded $3.5 million in research grant funds to Penn Medicine researchers and community partners…
A national network of researchers investigating the effective early intervention methods for toddlers with or at-risk for Autism Spectrum Disorder (ASD) have secured over $14…
A Marshall University investigator received just under a $400,000 grant to study the differences in brain development between males and females. Christopher Risher, PhD, assistant professor…
Researchers from Massachusetts General Hospital (MGH), the Harvard T.H. Chan School of Public Health as well as the Beth Israel Deaconess Medical Center recently shared…
With no known treatment and symptoms involving functional decline and the potential for death, Aberdeen University in Scotland recently signed on to a clinical trial…
How do genetic and non-genetic risk factors contribute to an individual’s Alzheimer’s risk as well as support investigator research to better understand some of the…
University of Florida (UF) researchers will broadly test a new artificial intelligence tool aimed at distinguishing the precise diagnosis for patients with early Parkinson’s disease…
TrialSite emphasizes the critical importance of finding a cure to Alzheimer’s disease, a disease that robs the individual of perhaps the most important, most cherished…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
